Phase 2 Stomach Cancer Trial, Recruiting NCT05934331 Sponsor: LaNova Medicines Zhejiang Co., Ltd. Condition: Stomach Cancer
Back to Stomach Cancer

Phase 2 Stomach Cancer Trial, Recruiting

NCT05934331
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are willing to take part and sign a consent form before any procedures begin.
  • You are between 18 and 80 years old (inclusive).
  • You are generally able to carry out daily activities with little or no limitation (confirm with trial site regarding specific fitness level required).
  • You are expected to live for at least 3 more months.
  • You have been diagnosed with an advanced gastrointestinal (digestive system) tumour that has been confirmed by a tissue or cell sample, and standard first-line treatment has not worked for you or you were unable to tolerate it.
  • Your tumour tests positive for a specific protein called CLDN18.2.
  • You have at least one tumour that can be measured on a scan.
  • Your blood test results show that your organs (such as liver, kidneys, and bone marrow) are working well enough, tested within 7 days before starting treatment.
  • You are able to communicate clearly with the research team and are willing and able to follow the study requirements.

Who may not be able to join:

  • You have a type of stomach or oesophageal cancer known to be HER2-positive.
  • You have taken part in another clinical trial within the 28 days before starting this trial.
  • You have received any anti-cancer treatment within 21 days before starting this trial.
  • You previously had serious immune-related side effects from immunotherapy, including a serious heart inflammation (confirm with trial site for specific groups this applies to).
  • You still have side effects from a previous cancer treatment that have not improved to a mild level.
  • You currently have moderate or severe nerve problems affecting your feelings or movement in your hands or feet.
  • You have pain from your cancer that cannot be controlled.
  • You have cancer that has spread to your brain or spinal cord and is causing symptoms or is currently active.
  • You have a build-up of fluid in body cavities (such as the abdomen or chest) that cannot be controlled.
  • You have a known allergy or serious reaction to antibody-based treatments.
  • You have previously been treated with a drug that targets the same protein as the treatment in this trial.
  • You have taken certain strong medications that affect how the liver breaks down drugs, within 14 days before starting the trial (confirm with trial site for specific medications).
  • You have received a live vaccine within 28 days before starting the trial.
  • You have a current or past lung condition called interstitial lung disease or pneumonia that required steroid tablets or injections as part of your treatment.
  • You are currently taking blood-thinning medications such as heparin or warfarin.
  • You have ongoing, uncontrollable vomiting that keeps coming back.
  • You have had severe, uncontrolled gastrointestinal bleeding, ulcers, or diarrhoea within the 28 days before starting the trial.
  • You have had a major operation or significant medical procedure within 28 days before starting the trial.
  • You have been diagnosed with another type of cancer within the past 2 years.
  • You have a serious heart or cardiovascular condition.
  • You have another serious illness that is not well controlled.
  • You are taking steroid tablets or other medicines that suppress your immune system at a significant dose, within 2 weeks before starting the trial (confirm with trial site for specific doses).
  • You have a known history of an autoimmune disease (where the body's immune system attacks itself).
  • You have a history of a condition that weakens your immune system.
  • You have HIV, or an active hepatitis B or hepatitis C infection.
  • You are a woman who could become pregnant and have tested positive on a pregnancy test within 7 days before the first dose, or you are currently breastfeeding.
  • You have a known mental health condition that may make it difficult to follow the trial requirements.
  • The trial doctor has decided for any other reason that taking part would not be suitable for you.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Jin Li, Shanghai East Hospital

Phone: 021-68889618

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
LaNova Medicines Zhejiang Co., Ltd.
Registry
ClinicalTrials.gov
Start date
27 July 2023
Est. completion
1 July 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

PFS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov